2003
DOI: 10.1007/s00772-003-0319-y
|View full text |Cite
|
Sign up to set email alerts
|

Medizinische und �konomische Aspekte der Zentrumsbildung in der Wundbehandlung

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
5
0
3

Year Published

2006
2006
2018
2018

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 9 publications
0
5
0
3
Order By: Relevance
“…These biofilm communities are known to be more resistant to physical and chemical stresses than planktonic cells and can cause major economic loss within industrial sectors (7). Moreover, more than 4 million people in Germany suffer from chronic wounds, which are often caused by resistant biofilm-forming pathogens (8). The treatment costs for these patients amount to up to 4 billion euros per year in Germany alone (9).…”
mentioning
confidence: 99%
“…These biofilm communities are known to be more resistant to physical and chemical stresses than planktonic cells and can cause major economic loss within industrial sectors (7). Moreover, more than 4 million people in Germany suffer from chronic wounds, which are often caused by resistant biofilm-forming pathogens (8). The treatment costs for these patients amount to up to 4 billion euros per year in Germany alone (9).…”
mentioning
confidence: 99%
“…Auf dem Boden verbesserter Behandlungsmöglichkeiten, einer Zunahme gefäßkranker Patienten sowie übergeordneter Forderungen nach interdisziplinä-rer Kooperation wurden auch in Deutschland Gefäßzentren gebildet [4,11].…”
Section: Diskussionunclassified
“…These biofilm communities are known to be more resistant to physical and chemical stresses compared to planktonic cells, and can cause major economic loss within industrial sectors (4). Moreover, more than four million people in Germany suffer from chronic wounds, which are often caused by resistant biofilm-forming pathogens (5). The treatment costs of these patients amount up to four billion euro per year only in Germany (6).…”
Section: Introductionmentioning
confidence: 99%